Navigation Links
Codeine-based painkillers to be used cautiously

Pharmacists advise that people should be aware of the dangers of overusing the opium-based drug codeine found in many painkillers.//

People should consult their pharmacist before taking painkillers. This was suggested by the Irish Pharmaceutical Union (IPU).

“These medicines, which are available directly from your pharmacist, are very effective in relieving the symptoms of headaches and other forms of pain. Irish pharmacists often recommend these medicines to treat pain,” Darragh O’Loughlin, a Galway pharmacist, said.

“However, prolonged regular use, except under medical supervision, may lead to physical and psychological dependence, addiction and result in withdrawal symptoms, such as restlessness and irritability once the patient stops taking the medication. Pharmacists always recommend consulting your doctor if symptoms have not eased with a couple of days’ treatment using over-the-counter medicines.”

Some over-the-counter medicines like Solpadeine and Nurofen Plus contain codeine, according to the union, representing 1,600 pharmacists.

“Patients who use pain relievers regularly over a prolonged period of time may experience rebound headaches. Pain relievers offer quick relief for occasional headaches. But there’s a limit – taking pain medication more than two or three days a week may actually contribute to headaches rather than easing them. It’s a cycle known as rebound headaches,” he said.

“Many types of pain relievers can contribute to rebound headaches, if you exceed the recommended daily dose.” According to him, rebound headaches were more common in people taking a medicine having a combination of codeine, caffeine and paracetamol as ingredients.

“Excessive use of some types of pain medication also may cause stomach ulcers, liver damage and kidney problems. Patients with symptoms persisting for more than three days should contact their pharmacist or doctor for best advice on a course of treatment,” he said.

Source-Mdindia
GYT
'"/>




Related medicine news :

1. Drug dilemma confronts users of painkillers
2. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... ... 11, 2016 , ... Life is known for throwing curves. It’s thrown quite ... gather once a year to play softball to raise money through Sun Health ... than 50 players who competed in this year’s softball tournament share a history of ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... their ongoing community involvement program, introduces a new charity campaign to raise funds ... are now being accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) ...
(Date:2/11/2016)... ... 2016 , ... From March 4 through 6, Hidrex ... at the Walter E. Washington Convention Center in Washington, D.C. , At the ... hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company will be talking ...
(Date:2/11/2016)... Ore. (PRWEB) , ... February 11, 2016 , ... ... Medicaid coverage results in significantly higher rates of several common cancer screenings, especially ... resulting in better outcomes and survival rates. , The study,“What Does Medicaid ...
(Date:2/10/2016)... ... ... Early this week, Team Iconic at J. Walter Thompson and Nestlé KITKAT ... global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé Cocoa Plan aims ... activities that focus on better farming, better lives and better cocoa. In order to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial ... 31, 2015. --> --> Revenue ... $69.1 million in the fourth quarter of 2014, an increase of ... compared with the same period in the prior year. ... in the fourth quarter of 2015, an increase of 9 percent ...
(Date:2/10/2016)... HERTFORDSHIRE, England och ... -- Erbjudandet lämnas inte, och detta ... eller indirekt, i eller till, och inga ... uppdrag av aktieägare i, något land där ... av accept av Erbjudandet skulle strida mot ...
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced ... December 31, 2015. --> --> ... revenues of $9.45 billion, up 28% on a constant ... of $9.43 billion. Excluding the impact of the acquisition ... generics business (the "EPD Business"), full year adjusted total ...
Breaking Medicine Technology: